Galapagos NV
GLPG
#4961
Rank
โ‚น177.10 B
Marketcap
โ‚น2,637
Share price
0.00%
Change (1 day)
6.60%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚น177.10 Billion

As of June 2026 Galapagos NV has a market cap of โ‚น177.10 Billion. This makes Galapagos NV the world's 4961th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น177.10 B-9.36%
2025โ‚น195.39 B26.61%
2024โ‚น154.32 B-30.79%
2023โ‚น223.00 B-7.77%
2022โ‚น241.77 B-11.08%
2021โ‚น271.90 B-42.58%
2020โ‚น473.53 B-50.85%
2019โ‚น963.38 B174.51%
2018โ‚น350.95 B14.45%
2017โ‚น306.65 B51.43%
2016โ‚น202.50 B23.62%
2015โ‚น163.81 B352.89%
2014โ‚น36.17 B-6.59%
2013โ‚น38.72 B25.14%
2012โ‚น30.94 B63.99%
2011โ‚น18.86 B-1.02%
2010โ‚น19.06 B61.18%
2009โ‚น11.82 B139.45%
2008โ‚น4.93 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น55.141 T 31,034.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น14.606 T 8,147.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น38.263 T 21,504.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.073 T 5,587.74%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น27.962 T 15,688.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น26.363 T 14,785.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น10.114 T 5,610.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚น8.75 B-95.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.834 T 2,065.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel